Literature DB >> 12461152

Seizures after alendronate.

Richard J Maclsaac1, Ego Seeman, George Jerums.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12461152      PMCID： PMC1279292          DOI： 10.1258/jrsm.95.12.615

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  Hypocalcemia associated with alendronate.

Authors:  D H Schussheim; T P Jacobs; S J Silverberg
Journal:  Ann Intern Med       Date:  1999-02-16       Impact factor: 25.391

2.  Anticonvulsant-induced bone disease: a plea for monitoring and treatment.

Authors:  H J Heller; K Sakhaee
Journal:  Arch Neurol       Date:  2001-09

3.  Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk.

Authors:  J E Compston
Journal:  BMJ       Date:  1998-11-28

4.  Hypoparathyroidism unmasked by alendronate.

Authors:  A S Kashyap; S Kashyap
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

5.  The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women.

Authors:  S T Harris; B J Gertz; H K Genant; D R Eyre; T T Survill; J N Ventura; J DeBrock; E Ricerca; C H Chesnut
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

6.  Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.

Authors:  B G Stuckey; E M Lim; G N Kent; L C Ward; D H Gutteridge
Journal:  J Bone Miner Res       Date:  2001-09       Impact factor: 6.741
  6 in total
  7 in total

1.  Seizure associated with zoledronic Acid therapy: side-effects or coincidental finding?

Authors:  Rashmi Ranjan Das
Journal:  Ther Adv Endocrinol Metab       Date:  2011-08       Impact factor: 3.565

2.  Neuron subset-specific Pten deletion induces abnormal skeletal activity in mice.

Authors:  Joaquin N Lugo; Marjorie H Thompson; Philippe Huber; Gregory Smith; Ronald Y Kwon
Journal:  Exp Neurol       Date:  2017-02-02       Impact factor: 5.330

Review 3.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

4.  SEIZURES ASSOCIATED WITH ZOLEDRONIC ACID (ZA) THERAPY: A CASE REPORT AND REVIEW OF THE LITERATURE.

Authors:  Roy Shalit; Liana Tripto-Shkolnik
Journal:  AACE Clin Case Rep       Date:  2020-08-06

Review 5.  Seizures Associated With Bone Density Conservation Agents.

Authors:  Kuan Sturgill; Justin P Reinert
Journal:  J Pharm Technol       Date:  2022-01-26

Review 6.  Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment.

Authors:  Gagandeep Singh; Jeremy H Rees; Josemir W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

Review 7.  Hypocalcemia-induced seizure: demystifying the calcium paradox.

Authors:  Pengcheng Han; Bradley J Trinidad; Jiong Shi
Journal:  ASN Neuro       Date:  2015-03-24       Impact factor: 4.146
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.